ASIM HARACIC: Open Payments
NPI 1821025834 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 12 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $38 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 4 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
Products named: REXULTI, AUSTEDO XR, INGREZZA, INVEGA SUSTENNA.
Industry payments across DC — which companies pay providers there.
